A specialist clinical research organization serving Boston's life sciences community

Boston sits at the intersection of world-class academic research and serious clinical development ambition. Niche Science & Technology brings over 25 years of specialist expertise in regulatory affairs, medical writing and clinical operations to the biotechnology and pharmaceutical companies turning that research into regulated, FDA-ready programs.
25+ years in clinical research
150+ biotech partners worldwide

Why Boston sponsors work with Niche

Kendall Square, the Longwood Medical Area and the Route 128 corridor have made Greater Boston one of the most productive life sciences ecosystems in the United States. The concentration of academic medical centers, teaching hospitals and research institutions here is extraordinary, and it generates a steady pipeline of science that is ready to move from discovery into clinical development.

That move is rarely straightforward. Translating academic research into a regulated clinical program requires a different kind of discipline, one built around FDA expectations, documented quality systems, and the kind of regulatory writing that stands up to scrutiny. Many Boston-area sponsors, particularly those spinning out of academic institutions or running their first IND program, find that gap between scientific confidence and regulatory readiness is wider than they anticipated.

Niche exists to close that gap. We are a specialist clinical research organization with over 25 years of experience supporting sponsors through exactly this transition, bringing regulatory precision, operational discipline and medical writing expertise that academic research environments rarely develop in-house.
Find More About Us

Clinical operations, regulatory affairs and medical communications, delivered with 25 years of expertise behind every engagement

Three specialist disciplines, fully integrated, covering everything your clinical program needs from first study to final submission.

Clinical Operations

Managing a clinical program in one of the most competitive talent markets in the country demands operational discipline and scientific understanding in equal measure. We support sponsors through project management, Trial Master File and document management, study monitoring, site management and quality and vendor management systems. Your program, on track and on record.

Regulatory Affairs

For Boston sponsors navigating FDA for the first time, or managing a complex submission after years of development, the quality of regulatory strategy and documentation defines the pace of progress. We provide regulatory writing, strategic advice, agency submissions, QC and redaction services, and legal representation for non-US sponsors. We know what the FDA needs to see, and we help you present it without ambiguity.

Medical Communications

Boston's research culture produces science that deserves to be heard. Whether you are planning a publication strategy around a Phase II dataset, building a medical education program for a new therapeutic area, or preparing for a major congress, we handle strategic communications, publication planning, editorial and submission services, medical illustration and grant applications. Your science, communicated with the authority it has earned.

Supporting Boston's clinical development community

Greater Boston's life sciences ecosystem is built on academic depth. The research networks connecting Harvard, MIT, Boston University and the Longwood Medical Area create programs of genuine scientific complexity, and the sponsors emerging from those networks often need a CRO that understands both the science and the regulatory path ahead.

 We understand the pressures of a founder-led biotech preparing its first IND, the complexity of a rare disease program navigating FDA's evolving frameworks, and the documentation demands of a late-phase regulatory submission under intense investor scrutiny.

Rare disease and orphan drug development

Boston is home to some of the world's leading rare disease research institutions. As FDA's regulatory landscape for ultra-rare and orphan indications continues to evolve, having a CRO partner with deep regulatory expertise in this space is no longer optional.
Read About FDA's New Framework for Ultra-Rare Disease Therapies

From investigator-initiated trial to regulated development

Many Boston sponsors begin as academic investigators running IITs before transitioning into commercially sponsored clinical programs. That transition brings a new layer of regulatory, operational and documentation requirements that Niche is built to support.
Read About Making Investigator-Initiated Trials Work

Practical resources for clinical development teams

Our Insider's Insights series translates over 25 years of hands-on experience in regulatory affairs, medical writing and clinical project management into free, downloadable guides. Covering Investigator's Brochures, clinical study reports, protocol development, publication planning and regulatory strategy, they are built for the clinical teams who are doing the work, not reading about it.

Recent Insider's Insights

Holding a meeting

Meetings are a necessary evil but handled badly they can be a terrible waste of time. We provide insights on conducting...

Handling Rejection

All authors will get some form of rejection from a journal at one time during in their careers. We offer some insights...

Concept Protocols

Concept protocols are short, flexible documents that can be reviewed quickly and edited easily. We provide some insights...

A track record built on complex programs

Our case histories span rare disease, oncology, gene therapy and large-scale research initiatives. The common thread is scientific complexity, and the operational and regulatory precision required to navigate it.

Let's talk about your program.

Get our latest news and publications

Sign up to our news letter

© 2025 Niche.org.uk     All rights reserved

HomePrivacy policy Corporate Social Responsibility